(1)
IDENTIFYING CONTRIBUTING VARIABLES AND DELAYED ADVERSE RESPONSES IN WHOLE BLOOD DONORS. Int. Res. J. Pharm. 2024, 15 (3), 32-37. https://doi.org/10.56802/t7q9nw43.